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Available online 12 September 2006Abstract—In the present work, we report the determination of phenolic compounds in ‘alcaparra’ table olives by reversed-phase
HPLC/DAD, and the evaluation of their extract in vitro activity against several microorganisms that may be causal agents of human
intestinal and respiratory tract infections, namely Gram positive (Bacillus cereus, Bacillus subtilis, and Staphylococcus aureus), Gram
negative bacteria (Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniae) and fungi (Candida albicans and Cryptococ-
cus neoformans). Three ﬂavonoidic compounds were identiﬁed and quantiﬁed: luteolin 7-O-glucoside, apigenin 7-O-glucoside, and
luteolin. At low concentrations (0.05 mg/mL) ‘alcaparra’ extract revealed signiﬁcant inhibition of both Gram positive and Gram
negative bacteria growth, with exception of P. aeruginosa. Nevertheless, no antifungal activity was observed at the tested
concentrations.
 2006 Elsevier Ltd. All rights reserved.1. Introduction
In the Mediterranean basin, olive oil, together with red
wine, fruits, vegetables, and ﬁsh, are important constit-
uents of the diet and are considered major factors in pre-
serving a healthy and relatively disease-free population.
In fact, epidemiological data show that the Mediterra-
nean diet has signiﬁcant protective eﬀects against cancer
and coronary heart disease.1,2 Olive products, typical
components of the Mediterranean diet, contain high
concentrations of complex phenols, which are endowed
with strong antioxidant activity.3,4 The most important
classes of phenolic compounds in olive products, namely
table olives, include phenolic acids, phenolic alcohols,
ﬂavonoids, and secoiridoids.5–10
Many researches have demonstrated that the above-
mentioned biocompounds are able to inhibit or delay0968-0896/$ - see front matter  2006 Elsevier Ltd. All rights reserved.
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gi,11 so that they might be used as alternative food addi-
tives or in integrated pest management programmes.
The increasing resistance to antibiotic represents the
main factor justifying the need to ﬁnd and/or develop
new antimicrobial agents. Thus, some studies have
focused on the antimicrobial agents and on the antimi-
crobial properties of plant-derived active principles
(such as spices and essential oils), which have been used
for a long time in traditional medicine to overcome
infections.11 The use of crude extracts instead of isolated
constituents may be more appropriate since a speciﬁc
compound could be bioactive but the presence of other
compounds present in the extracts could change its
properties.
Recent studies on antimicrobial activity of olive prod-
ucts were developed, namely with olive leaves,12 olive
fruits13 and their pure compounds, such as oleurop-
ein14,15 and hydroxytyrosol,14 and aliphatic aldehydes.16
Hydroxytyrosol and oleuropein have been shown to
inhibit or delay the rate of growth of a range of bacteria
and microfungi like Haemophilus inﬂuenza, Salmonella
8534 A. Sousa et al. / Bioorg. Med. Chem. 14 (2006) 8533–8538typhi, Vibrio parahaemolyticus and Staphylococcus aure-
us.14 Also, oleuropein inhibited the growth ofMycoplas-
ma hominis, Mycoplasma fermentans, Mycoplasma
pneumoniae and Mycoplasma pirum.15 Aldehydes, such
as hexanal, nonanal, (E)-2-hexenal, (E)-2-heptenal,
(E)-2-octenal and (E)-2-nonenal revealed antifungal
activity against Trycophyton mentagrophytes, Microspo-
rum canis and Candida spp.16
In the Northeast of Portugal, stoned halved olives (table
olives), known as ‘alcaparra’, are largely produced and
commercialized in the local market, constituting an
important agro-economic factor for the local producers.
This kind of table olives are processed from green or yel-
low-green healthy olive fruits, which are broken using a
wood hammer, being the pulp and stone separated. The
pulp is sliced into two approximately equal parts, per-
pendicularly to the major axis of the fruit, and placed
in water, daily changed during a week to remove its bit-
terness. As far as we know, there are no reports on the
nature and/or concentrations of phenolic compounds
in ‘alcaparra’ olive and on its antimicrobial activity.
Therefore, in the present work, the phenolic compounds
of this kind of Portuguese table olives were determined.
A screening of ‘alcaparra’ extracts, antibacterial activi-
ties against Gram positive (Bacillus cereus, B. subtilis
and Staphylococcus aureus) and Gram negative bacteria
(Pseudomonas aeruginosa, Escherichia coli and Klebsiella
pneumoniae) and of antifungal capacity (Candida albi-
cans, Cryptococcus neoformans) was also performed.2. Results and discussion
2.1. Phenolic compounds in ‘alcaparra’ olives
‘Alcaparra’ table olives presented a chemical proﬁle
composed of three identiﬁed phenolic compounds: lute-
olin 7-O-glucoside, apigenin 7-O-glucoside, and luteolin
(Figs. 1 and 2). Three unidentiﬁed ﬂavonoidic com-
pounds (a, b, and c) and one hydroxycinnamicO
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Figure 1. Flavonoid compounds identiﬁed in the ‘alcaparra’ sample.derivative were also detected in the methanolic extract
(Fig. 2). The existence of several other compounds,
namely hydroxytyrosol, tyrosol, 5-O-caﬀeoylquinic acid,
verbascoside, cyanidin 3-O-glucoside, cyanidin 3-O-ruti-
noside, oleuropein, rutin, and quercetin 3-O-rhamno-
side, described in olive fruits,8 was also checked, but it
were not detected in the analysed sample. Other extrac-
tion solvents were used, namely hydromethanol and
water, presenting all the extracts the same qualitative
composition and similarities in the quantitative analysis.
This happens, once traditional stoned table olives ‘alca-
parra’ suﬀered a treatment which includes several wash-
es with water, so the most polar compounds are not
present in highest amounts in the analysed ‘alcaparra’
samples. So, the three mentioned solvents extract the
phenolic compounds to the same extent. As expected,
in all the extractions with the mentioned solvents, luteo-
lin was the major phenolic compound (data not shown).
As methanol comprised more compounds of several dif-
ferent polarities than the others, it was chosen for the
quantiﬁcation purposes, allowing a better comparison
between the ‘alcaparra’ olives and other types of olives.
As far as we know, it is the ﬁrst time that information
about phenolic compounds in ‘alcaparra’ stoned table
olives is reported. The quantiﬁcation of the identiﬁed
phenolics (Table 1) revealed that luteolin was the com-
pound present in the highest amount, corresponding to
ca. 91% of total amount of identiﬁed compounds, while
apigenin 7-O-glucoside was the minor one (ca. 1% of to-
tal phenolics).
Several studies on phenolic composition of other diﬀer-
ent kinds of table olives, namely Spanish-style green ol-
ives in brine, naturally or turning colour table olives in
brine, Kalamata olives in brine and oxidized table olives
in brine were performed.7,17–20 These studies showed
that the major phenolic compounds presented in table
olives were tyrosol, hydroxytyrosol, and oleanolic acid
and that their concentration depended on the degree
of maturation and on the treatment method of olive
drupe untill they become edible.O
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Figure 2. HPLC phenolic proﬁle of ‘alcaparra’ table olives sample. Detection at 320 nm. (1) Luteolin 7-O-glucoside; (2) apigenin 7-O-glucoside; (3)
luteolin; (a), (b), (c) unidentiﬁed ﬂavonoidic derivatives; (d) unidentiﬁed hydroxycinnamic acid derivative.
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that is most probably related with the technological pro-
cess to which they are subjected. As mentioned above,
the bitterness of ‘alcaparra’ is removed in the pulp wash-
ing, and this may justify the absence of secoiridoids like
oleuropein. In addition, glycosidic phenolic compounds
and other polar compounds presenting higher water sol-
ubility may also be extracted during this process, leading
to its loss. So, due to its less polarity than other pheno-
lics, the existence of a very high content of luteolin in
‘alcaparra’ table olives is not surprising.
2.2. Antimicrobial assays
The ‘alcaparra’ aqueous extract was screened for its
antimicrobial activity against B. cereus, B. subtilis, S.
aureus (Gram positive), E. coli, P. aeruginosa, K. pneu-
moniae (Gram negative) bacteria, and C. albicans andTable 1. Phenolic compounds content in table olive ‘alcaparra’ sample
(mg/kg, dry basis)a
Compound Mean SD
1 Luteolin 7-O-glucoside 9.3 0.1
2 Apigenin 7-O-glucoside 1.4 0.0
3 Luteolin 111.7 2.5
P
122.4
a Results are expressed as means of three determinations. SD, standard
deviation.
P
, sum of the identiﬁed phenolic compounds.
Table 2. Antimicrobial activity of the ‘alcaparra’ extract
Samples M
B. cereus B. subtilis S. aureus P. aeruginos
Alcaparra 25 25 25 50
(+ + + +) (+ +) (+ +) ()
Ampicillin 0.00313 0.0125 0.00625 0.00625
(+ + + +) (+ + + +) (+ + + +) (+ + + +)
Cycloheximide NT NT NT NT
No antimicrobial activity (), inhibition zone <1 mm. Slight antimicrobial
(+ +), inhibition zone 4–5 mm. High antimicrobial activity (+ + +), inhibition
>9 mm. Standard deviation ±0.5 mm. NT, not tested.C. neoformans (fungi). Aside from concerns with food
quality degradation, these microorganisms may be caus-
al agents of intestinal infections in humans. The minimal
inhibitory concentration (MIC) values for bacteria and
fungi (Table 2) were determined as an evaluation of
the antimicrobial activity of the tested ‘alcaparra’
sample.
The extract inhibited all the tested bacteria, with the
exception of P. aeruginosa (Gram negative). B. cereus
and K. pneumoniae were the most sensitive Gram posi-
tive and Gram negative bacteria, respectively (Table
2). However, the tested fungal species C. albicans and
C. neoformans were resistant to ‘alcaparra’ extract.
As expected, the MICs of antibacterial (ampicillin) and
antifungal (cycloheximide) control standards were lower
than those for ‘alcaparra’ extract. Usually, pure active
compounds reveal to have more activity than crude
extracts.
Only the microorganisms that exhibited susceptibility in
the screening performed in solid medium were submitted
to assays in liquid medium, in order to determine their
growth rates. The values obtained suggested a broad
antimicrobial activity of ‘alcaparra’ extract in a concen-
tration-dependent manner, against the tested bacterial
strains. According to the percentage of inhibition of
bacteria growth in the presence of diﬀerent extract
concentrations (Fig. 3) ‘alcaparra’ extract presentedIC (mg/mL)
a E. coli K. pneumoniae C. albicans C. neoformans
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Figure 3. Inhibition (%) of bacterial growth by diﬀerent concentra-
tions of ‘alcaparra’ extract.
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niae > B. cereus > B. subtilis > S. aureus (Table 3). The
extract at a concentration of 10 mg/mL decreased the
absorbance values at 540 nm (Fig. 4), indicating inhibi-
tion of bacteria growth relatively to the control (without
extract) during 24 h of incubation.
Certainly the chemical composition of ‘alcaparra’ ex-
tract conditioned the antibacterial eﬀects observed.
The high content of luteolin and the other phenolic com-
pounds identiﬁed in the extract might contribute for its
antimicrobial properties. In fact, the antimicrobial ac-
tion of phenolics is well known and it is related to their
ability to denature proteins, being generally classiﬁed as
surface-active agents.21 They act by causing the leakage
of cytoplasmic constituents such as protein, glutamateTable 3. IC50 values of ‘alcaparra’ extract
Bacterial species IC50 (mg/mL)
B. cereus 0.981
B. subtilis 2.445
S. aureus 2.841
E. coli 0.722
K. pneumoniae 0.813or potassium and phosphate from bacteria, which may
be due to disruption of cell peptidoglycan or damage
of the cell membrane. The mode of action of phenolic
compounds has been shown to be concentration depen-
dent.11,15 In particular, luteolin has been described to
possess antimicrobial activity against several bacterial
species.22–25
In conclusion, data obtained in this study demonstrate
that ‘alcaparra’ table olives may be a good candidate
for employment as antimicrobial agent against bacteria
responsible for human gastrointestinal and respiratory
tract infections. These results are particularly important
against S. aureus, a microorganism extensively studied
due to its ability to produce enterotoxins, and against
E. coli, both exceptionally resistant to a number of phy-
tochemicals. Thus, it seems that dietary intakes of ‘alca-
parra’ may lower the risk of bacterial infections
particularly in the intestinal tract, mainly due to the pro-
tective action provided by its phenolic compounds.3. Experimental
3.1. ‘Alcaparra’ sample
‘Alcaparra’ traditional stoned olives were purchased at a
local market in Northeast Portugal and frozen. The
sample was then lyophilized, reduced to a ﬁne powder
(20 mesh) and stored in an exsiccator protected from
light.
3.2. Identiﬁcation and quantiﬁcation of phenolic
compounds
3.2.1. Standards. The standards used were from Sigma
(St. Louis, MO, USA) or Extrasynthe`se (Genay,
France). Methanol and formic acid were obtained from
Merck (Darmstadt, Germany). The water was treated in
a Milli-Q water puriﬁcation system (Millipore, Bedford,
MA, USA) before use.
3.2.2. Extraction of phenolic compounds. The extraction
was achieved as previously reported26 with some modi-
ﬁcation: each sample (ca. 1.5 g) was thoroughly mixed
with methanol until complete extraction of these com-
pounds (negative reaction to NaOH 20%). The metha-
nolic extract was ﬁltered, evaporated to dryness under
reduced pressure (40 C) and redissolved in methanol
(2 mL) of which 20 lL was injected for HPLC analysis.
3.2.3. HPLC-DAD system for analysis of phenolic
compounds. Chromatographic separation was carried
out as reported previously,26 with an analytical HPLC
unit (Gilson), using a Spherisorb ODS2 column
(250 · 4.6 mm, RP-18, 5 lm particle size, Merck,
Darmstadt, Germany) with the solvent system water/
formic acid (19:1) (A) and methanol (B), starting with
5% methanol and installing a gradient to obtain 15%
B at 3 min, 25% B at 13 min, 30% B at 25 min, 35% B
at 35 min, 40% B at 39 min, 45% B at 42 min, 45% B
at 45 min, 47% B at 50 min, 48% B at 60 min, 50% B
at 64 min, 100% B at 66 min, and 100% B at 68 min.
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Figure 4. Bacterial growth in the presence of ‘alcaparra’ extract (10 mg/mL) and in the absence of extract (0 mg/mL) along the incubation period.
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with a diode array detector, and chromatograms were
recorded at 280, 320, and 500 nm. Spectral data from
all peaks were accumulated in the range 200–600 nm.
The data were processed on a Unipoint system soft-
ware (Gilson Medical Electronics, Villiers le Bel,
France). Peak purity was checked by software contrast
facilities.
Phenolic compounds, quantiﬁcation was achieved by the
absorbance recorded in the chromatograms relative to
external standards at 350 nm.
3.3. Antimicrobial activity
3.3.1. Materials and reagents. Ampicillin and cyclohexi-
mide (analytical standard compounds)were of the highest
available quality and purchased fromMerck (Darmstadt,
Germany). Water was treated in aMilli-Q water puriﬁca-
tion system (TGI Pure Water Systems, USA).
3.3.2. Extract preparation. Powdered sample (5 g) was
extracted with 250 mL of boiling water for 45 min and
ﬁltered through Whatman No. 4 paper. The aqueous ex-
tract was frozen, lyophilized, and redissolved in water at
a concentration of 50 mg/mL, and analysed for their
antimicrobial activity.3.3.3. Microorganisms and culture conditions. The bacte-
rial strains used were B. cereus CECT 148, B. subtilis
CECT 498, S. aureus ESA 7, E. coli CECT 101, P. aeru-
ginosa CECT 108 and K. pneumoniae ESA 8. The fungi
strains used were C. albicans CECT 1394 and C. neofor-
mans ESA 3. Microorganisms CECT were obtained
from the Spanish-type culture collection (CECT) of
Valencia University, while microorganisms ESA were
clinically isolated strains identiﬁed in Microbiology
Laboratory of Escola Superior Agra´ria de Braganc¸a.
Microorganisms were cultured aerobically at 37 C in
nutrient agar medium for bacteria and at 30 C (Scien-
tiﬁc 222 oven model, 2003) in Sabouraud dextrose agar
medium for fungi. Before experimental use, cultures
from solid medium were subcultivated in liquid media,
incubated and used as the source of inoculums for each
experiment.
3.3.4. Preliminary assays for antimicrobial activity. A
screening of antibacterial activities with three Gram neg-
ative (E. coli, P. aeruginosa, and K. pneumoniae) and
three Gram positive bacteria (B. subtilis, B. cereus, and
S. aureus) was performed; antifungal activity (C. albi-
cans, C. neoformans) was also assessed, and the minimal
inhibitory concentrations (MICs in mg/mL) were deter-
mined by an adaptation of the agar streak dilution
8538 A. Sousa et al. / Bioorg. Med. Chem. 14 (2006) 8533–8538method based on radial diﬀusion.27,28 Suspensions of the
microorganism were prepared to contain approximately
108 cfu/mL, and the plates containing agar medium were
inoculated (100 lL). A 50 lL volume of each sample (2–
50 mg/mL) was pipetted into a hole (depth 3 mm, diam-
eter 4 mm) made in the centre of the agar. Under the
same conditions, diﬀerent concentrated solutions of
ampicillin (antibacterial) and cycloheximide (antifungal)
were used as control standards. The assays with the
standards were carried out using DMSO solutions be-
cause water could not dissolve the compounds. After
toxicity assays this solvent showed to be not toxic (did
not inhibited per si microorganisms growth).
The MIC was considered to be the lowest concentration
of the tested sample to inhibit growth of bacteria or fun-
gi on the plate, after 24 h. The diameters of the inhibi-
tion zones corresponding to the MICs were measured
in millimetres with an accuracy of 0.5 mm using a ruler.
Each inhibition zone diameter was measured three times
(three diﬀerent plates) and the average was taken. A
control using only inoculation was also carried out.
3.3.5. Test assays for antibacterial activity. A macro-
broth-dilution technique was used to determine the
growth inhibition of the susceptible bacteria (B. subtilis,
B. cereus, S. aureus, E. coli and K. pneumoniae) to ‘alca-
parra’ previously screened using the radial diﬀusion on
agar. A nutrient medium (10 g tryptone, 5 g meat extract
and water to 1 L) was used to prepare the inocula after
being sterilized in an autoclave (P Selecta model, 2002)
at 121 C for 20 min). Erlenmeyer ﬂasks (50 mL) with
10 mL of the liquid culture medium were inoculated
with the bacteria suspension (108 cfu/mL) and each ex-
tract concentration to be tested (0.05–10 mg/mL) was
added. Incubation was carried out for 24 h at 37 C in
a rotary shaker (Stuart Scientiﬁc SI50 model, 2001) at
150 rpm. The growth of bacteria cultures was monitored
by measuring optical density at 540 nm in a UV–visible
spectrophotometer (Varian Cary 50 Scan model, 1998).
Controls were carried out in the same conditions but in
the absence of sample extract. All assays were carried
out under aseptic conditions. Values for bacteria growth
rate were obtained by linear regression analysis at the
exponential growth range in the graphs of optical densi-
ty at 540 nm versus incubation time. The equation curve
slope was considered the rate of bacteria growth and
was expressed relatively to the control (100%). IC50
values (extract concentration which inhibits 50% of
bacterial growth) were also determinate.References and notes
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